Supply of FDA-Approved Meloxicam Tablets (NSN 6505015413243)

The contract requires the manufacture or supply of exactly four bottles of FDA-approved Meloxicam Tablets that meet the Department of Defense’s National Stock Number standards, specifically NSN 6505015413243. The product must comply with all federal regulatory requirements for pharmaceuticals and be packaged and labeled in accordance with military logistics specifications. Delivery is mandated to a designated military logistics center located in Suffolk, Virginia, ensuring alignment with defense supply chain protocols. The procurement is structured as a subcontract under the Defense Logistics Agency, operating within the broader authority of the Department of Defense, and falls under the NAICS code 325412, which classifies it within drug manufacturing. The solicitation was posted on August 9, 2026, and is tied to an active contract vehicle identified by SPE2DX25D9900 with a delivery reference of SPE2DP26F8865. While no set-aside provisions or small business designations are specified, the transaction is governed by standard DoD procurement procedures, emphasizing quality control, regulatory compliance, and timely delivery. The absence of a point of contact or detailed office address suggests the transaction is processed through centralized DLA channels. All parties involved must ensure adherence to FDA standards, DoD inventory coding, and military delivery timelines to fulfill contractual obligations.